Company intelligence / Profile preview

Lexicor Medical Technology

Augusta, Georgia, United Stateshealthmanagement.org ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

Lexicor pioneered commercial quantitative EEG devices/software for neuropsychiatric assessment. Its NRS‑24 enabled objective brain mapping, while the DataLex web portal provided internet-based clinical decision support using baseline brain activity data. The NEBA System was cleared by the FDA as an aid to diagnose ADHD in patients aged 6–17 years.

Therapeutic areas: Psychiatry
Modalities: DeviceSoftware
Industry: Physiological Monitoring

Partnerships

Collaborated with leading clinicians/researchers in neurofeedback and neurometrics including Dr. Joe Kamiya, Dr. Joel Lubar, Dr. M. Barry Sterman, Dr. Robert Thatcher.

Beyond the preview

Go deeper on Lexicor Medical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lexicor Medical Technology.

Explore the full profile